Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer

Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer

kidneycancer

3 months
38 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Walter Stadler, MD FACP Dean for Clinical Research
Deputy Director Comprehensive Cancer Center University of Chicago discusses Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer at the 18th International Kidney Cancer Symposium 2019, Miami, FL.



Up Next Autoplay